WebFeb 15, 2012 · Blood Cancer Journal – DOAJ Blood Cancer Journal BCJ 2044-5385 (Online) Website ISSN Portal About Articles Publishing with this journal The journal charges up to: 3060 GBP as publication fees (article processing charges or APCs). There is a waiver policy for these charges. Look up the journal’s: Aims & scope Instructions for authors WebDec 24, 2024 · Cancer patients with COVID-19 represented 8.3% of deaths in the New York city area, and 7.6% of deaths from the Wuhan area in China. 5,6 An even higher fatality rate (20.3%) was observed in Italy. 7 A recent study aimed at identifying risk factors for death in cancer patients developing COVID-19 interestingly (but not surprisingly) reported age …
Did you know?
WebJan 18, 2012 · v.10(1) 2024 Jan: v.10(2) 2024 Feb: v.10(3) 2024 Mar: v.10(4) 2024 Apr: v.10(5) 2024 May: v.10(6) 2024 Jun: v.10(7) 2024 Jul: v.10(8) 2024 Aug: v.10(9) 2024 … WebNov 9, 2024 · DOI: 10.1038/s41408-018-0141-0 Abstract Substantial improvements in survival have been seen in multiple myeloma (MM) over recent years, associated with the introduction and widespread use of multiple novel agents and regimens, as well as the emerging treatment paradigm of continuous or long-term therapy.
WebOct 18, 2024 · Wei J, Zhao J, Han M, Meng F, Zhou J. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity. J Immunother Cancer. 2024;8:e000862. Article Google Scholar WebOct 16, 2024 · Blood Cancer J. 2024 Oct 16;10(10):102. doi: ... 6 Perlmutter Cancer Center, NY Langone Health, New York, ... with 6, 23, 46, and 63% risk of progression in …
WebOct 30, 2024 · Blood Cancer J. 2024 Oct 30;10(10):108. doi: 10.1038/s41408-020-00377-0. Authors Alejandro Medina 1 , Noemi Puig 1 , Juan Flores-Montero 2 , Cristina Jimenez … WebNov 23, 2024 · A recent phase-3 study compared VEN combined with either azacitidine or placebo, in the aforementioned study population; the complete remission (CR) and CR with incomplete count recovery (CRi) rates were 28.3% and 66.4%, respectively, and an improvement in overall survival was also demonstrated.
WebBlood Cancer J. 2024 Oct 30;10(10):107. PubMed PMID: 33127875 Pollyea DA, Pratz K, Letai A, Jonas BA, Wei AH, Pullarkat V, Konopleva M, Thirman MJ, Arellano M, Becker …
WebAug 5, 2024 · Blood Cancer J. 2024 Aug 5;10(8) ... Impaired performance status and history of infections within 30 days before CAR T cell therapy was a risk factor for severe bacterial infection. In conclusion, infections were common within the first 60 days after CAR T cell therapy, however, they were not associated with an increased risk of death. ... kool and the gang cherish the loveWebApr 28, 2024 · Blood Cancer Journal - Dissecting racial disparities in multiple myeloma—clues from differential immunoglobulin levels kool and the gang cancionesWebOct 30, 2015 · The goal of this paper is to provide a review of how MM is classified into specific subtypes based on primary cytogenetic abnormalities and to provide a concise overview of how to interpret cytogenetic abnormalities based on the disease stage to aid clinical practice and patient management. Publication types Research Support, N.I.H., … kool and the gang cherish wikiWebOct 30, 2024 · Blood Cancer Journal - New directions for emerging therapies in acute myeloid leukemia: the next chapter ... Blood Cancer J. 10, 107 (2024) ... Accepted: 09 … kool and the gang cherish music video hdWebOct 24, 2024 · FDA approval summary: Dalteparin for the treatment of symptomatic venous thromboembolism in pediatric patients. Margret Merino, Nicholas Richardson, Gregory Reaman, Anusha Ande, Simbarashe Zvada, Chao Liu, Sudharshan Hariharan, R. Angelo De Claro, Ann Farrell, Richard Pazdur. e28688. kool and the gang cherish the love videoWebOct 23, 2024 · Blood Cancer J. 2024 Oct 23;10(10):106. doi: 10.1038/s41408-020-00369-0. Authors ... 10 Emory University, Winship Cancer Institute, Atlanta, GA, USA. [email protected]. PMID: 33097687 PMCID: PMC7584571 DOI: 10.1038/s41408-020-00369-0 Abstract DREAMM-2 (NCT03525678) is an ongoing global, open-label, phase 2 … kool and the gang celebrate lpWebApr 28, 2024 · Although complement-dependent cytotoxicity (CDC) is a powerful Fc-mediated effector function for killing hematological cancer cells, CD37-specific antibodies are generally poor inducers of CDC. T … DuoHexaBody-CD37 ® , a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell … kool and the gang cherish wikipedia